SARS-CoV-2 evades natural killer cell cytotoxic responses

In a recent study posted to the bioRxiv* preprint server, researchers at Stanford University School of Medicine revealed the mechanism via severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escapes natural killer (NK) cell cytotoxic reactions.

The Development of Natural Killer Cells for Solid Tumor Treatment

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication

HCMV-secreted glycoprotein gpUL4 inhibits TRAIL-mediated apoptosis and NK cell activation

Immune system evasion – the HIV-infected cell

Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?, Cell Communication and Signaling

COVID-19: Immunology, vaccines and epidemiology: Week 2: 1.5 - OpenLearn - Open University

The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy: Molecular Therapy - Oncolytics

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

JCI - NK cell receptor and ligand composition influences the clearance of SARS-CoV-2